U.S. markets closed

Check-Cap Ltd. (CHEK)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.6700+0.0500 (+3.09%)
At close: 4:00PM EDT
1.6500 -0.02 (-1.20%)
After hours: 07:42PM EDT

Check-Cap Ltd.

Check-Cap Building
29 Abba Hushi Avenue PO Box 1271
Isfiya 30090
972 4 830 3401

IndustryDiagnostics & Research
Full Time Employees65

Key Executives

NameTitlePayExercisedYear Born
Mr. Alex OvadiaCEO & Director493.56kN/A1962
Dr. Yoav Kimchy Ph.D.Founder & Chief Technology Officer473.54kN/A1961
Ms. Mira RosenzweigChief Financial Officer291.36kN/A1972
Mr. Joshua BelkarVP of Operations253.2kN/A1969
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based system that utilizes low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule, which is designed to measure, collect, and transmit structural information; C-Scan Track, a disposable system attached to the patient's back via biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis and report generation. The company was founded in 2004 and is based in Isfiya, Israel.

Corporate Governance

Check-Cap Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.